These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 37318762)

  • 1. Post-exposure vaccine effectiveness and contact management in the mpox outbreak, Madrid, Spain, May to August 2022.
    Montero Morales L; Barbas Del Buey JF; Alonso García M; Cenamor Largo N; Nieto Juliá A; Vázquez Torres MC; Jiménez Bueno S; Aragón Peña A; Gil Montalbán E; Íñigo Martínez J; Alonso Colón M; Arce Arnáez A;
    Euro Surveill; 2023 Jun; 28(24):. PubMed ID: 37318762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acceptance and timeliness of post-exposure vaccination against mpox in high-risk contacts, Amsterdam, the Netherlands, May-July 2022.
    van Ewijk CE; Smit C; Bavalia R; Ainslie K; Vollaard A; van Rijckevorsel G; Hahné SJM
    Vaccine; 2023 Nov; 41(47):6952-6959. PubMed ID: 37838481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of Modified Vaccinia Ankara-Bavaria Nordic Vaccination in a Population at High Risk of Mpox: A Spanish Cohort Study.
    Fontán-Vela M; Hernando V; Olmedo C; Coma E; Martínez M; Moreno-Perez D; Lorusso N; Vázquez Torres M; Barbas Del Buey JF; Roig-Sena J; Pastor E; Galmés Truyols A; Artigues Serra F; Sancho Martínez RM; Latasa Zamalloa P; Pérez Martínez O; Vázquez Estepa A; García Rojas AJ; Barreno Estévez AI; Sánchez-Migallón Naranjo A; Pérez Martín JJ; Peces Jiménez P; Morales Romero R; Castilla J; García Cenoz M; Huerta Huerta M; Boone ALD; Macías Ortiz MJ; Álvarez Río V; Rodríguez Recio MJ; Merino Díaz M; Berradre Sáenz B; Villegas-Moreno MT; Limia A; Diaz A; Monge S;
    Clin Infect Dis; 2024 Feb; 78(2):476-483. PubMed ID: 37864849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimated Effectiveness of JYNNEOS Vaccine in Preventing Mpox: A Multijurisdictional Case-Control Study - United States, August 19, 2022-March 31, 2023.
    Dalton AF; Diallo AO; Chard AN; Moulia DL; Deputy NP; Fothergill A; Kracalik I; Wegner CW; Markus TM; Pathela P; Still WL; Hawkins S; Mangla AT; Ravi N; Licherdell E; Britton A; Lynfield R; Sutton M; Hansen AP; Betancourt GS; Rowlands JV; Chai SJ; Fisher R; Danza P; Farley M; Zipprich J; Prahl G; Wendel KA; Niccolai L; Castilho JL; Payne DC; Cohn AC; Feldstein LR; ;
    MMWR Morb Mortal Wkly Rep; 2023 May; 72(20):553-558. PubMed ID: 37200229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. JYNNEOS™ effectiveness as post-exposure prophylaxis against mpox: Challenges using real-world outbreak data.
    Rosen JB; Arciuolo RJ; Pathela P; Boyer CB; Baumgartner J; Latash J; Malec L; Lee EH; Reddy V; King R; Edward Real J; Lipsitch M; Zucker JR
    Vaccine; 2024 Jan; 42(3):548-555. PubMed ID: 38218669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and Safety of the Smallpox Vaccine for Postexposure Prophylaxis in Monkeypox: Protocol for an Open-Labeled, Single-Armed Study.
    Yano R; Terada-Hirashima J; Uemura Y; Tomita N; Shimizu Y; Iwasaki H; Okumura N; Suzuki T; Saito S; Ujiie M; Sugiura W; Ohmagari N
    JMIR Res Protoc; 2023 Aug; 12():e46955. PubMed ID: 37624623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of one dose of MVA-BN smallpox vaccine against mpox in England using the case-coverage method: an observational study.
    Bertran M; Andrews N; Davison C; Dugbazah B; Boateng J; Lunt R; Hardstaff J; Green M; Blomquist P; Turner C; Mohammed H; Cordery R; Mandal S; Campbell C; Ladhani SN; Ramsay M; Amirthalingam G; Bernal JL
    Lancet Infect Dis; 2023 Jul; 23(7):828-835. PubMed ID: 36924787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-dose Effectiveness of Mpox Vaccine in Quebec, Canada: Test-negative Design With and Without Adjustment for Self-reported Exposure Risk.
    Brousseau N; Carazo S; Febriani Y; Padet L; Hegg-Deloye S; Cadieux G; Bergeron G; Fafard J; Charest H; Lambert G; Talbot D; Longtin J; Dumont-Blais A; Bastien S; Dalpé V; Minot PH; De Serres G; Skowronski DM
    Clin Infect Dis; 2024 Feb; 78(2):461-469. PubMed ID: 37769158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of JYNNEOS Vaccine Against Diagnosed Mpox Infection - New York, 2022.
    Rosenberg ES; Dorabawila V; Hart-Malloy R; Anderson BJ; Miranda W; O'Donnell T; Gonzalez CJ; Abrego M; DelBarba C; Tice CJ; McGarry C; Mitchell EC; Boulais M; Backenson B; Kharfen M; McDonald J; Bauer UE
    MMWR Morb Mortal Wkly Rep; 2023 May; 72(20):559-563. PubMed ID: 37339074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breakthrough infection and reinfection in patients with mpox.
    Jiang W; Hu Y; Yang X; Hou L; Zhang J; Niu H; Hu C; Lin J
    Rev Med Virol; 2024 Mar; 34(2):e2522. PubMed ID: 38348583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mpox Outbreak - Los Angeles County, California, May 4-August 17, 2023.
    Leonard CM; Poortinga K; Nguyen E; Karan A; Kulkarni S; Cohen R; Garrigues JM; Marutani AN; Green NM; Kim AA; Sey K; Pérez MJ
    MMWR Morb Mortal Wkly Rep; 2024 Jan; 73(2):44-48. PubMed ID: 38236779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccine effectiveness of 3rd generation mpox vaccines against mpox and disease severity: A systematic review and meta-analysis.
    Pischel L; Martini BA; Yu N; Cacesse D; Tracy M; Kharbanda K; Ahmed N; Patel KM; Grimshaw AA; Malik AA; Goshua G; Omer SB
    Vaccine; 2024 Jun; ():. PubMed ID: 38906763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An open-label, non-randomized study investigating the safety and efficacy of smallpox vaccine, LC16, as post-exposure prophylaxis for mpox.
    Tomita N; Terada-Hirashima J; Uemura Y; Shimizu Y; Iwasaki H; Yano R; Suzuki T; Saito S; Okumura N; Sugiura W; Ohmagari N; Ujiie M
    Hum Vaccin Immunother; 2023 Aug; 19(2):2242219. PubMed ID: 37559375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of post-exposure vaccination by modified vaccinia Ankara to prevent mpox (formerly monkeypox): a retrospective observational study in Lyon, France, June to August 2022.
    Merad Y; Gaymard A; Cotte L; Perpoint T; Alfaiate D; Godinot M; Becker A; Cannesson O; Batalla AS; Oria-Yassir F; Landré S; Morfin F; Bouscambert M; Valour F; Ader F; Conrad A
    Euro Surveill; 2022 Dec; 27(50):. PubMed ID: 36695469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine Effectiveness of JYNNEOS against Mpox Disease in the United States.
    Deputy NP; Deckert J; Chard AN; Sandberg N; Moulia DL; Barkley E; Dalton AF; Sweet C; Cohn AC; Little DR; Cohen AL; Sandmann D; Payne DC; Gerhart JL; Feldstein LR
    N Engl J Med; 2023 Jun; 388(26):2434-2443. PubMed ID: 37199451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring and Characteristics of Mpox Contacts, Virginia, USA, May-November 2022.
    Field EN; McCarty E; Saady D; Darby B
    Emerg Infect Dis; 2024 Mar; 30(3):453-459. PubMed ID: 38237269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mpox outbreak 2022: an overview of all cases reported to the Cologne Health Department.
    Kröger ST; Lehmann MC; Treutlein M; Fiethe A; Kossow A; Küfer-Weiß A; Nießen J; Grüne B
    Infection; 2023 Oct; 51(5):1369-1381. PubMed ID: 36787016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of an Mpox Outbreak Affecting Many Vaccinated Persons in Chicago, Illinois-March 2023-June 2023.
    Faherty EAG; Holly T; Ogale YP; Spencer H; Becht AM; Crisler G; Wasz M; Stonehouse P; Barbian HJ; Zelinski C; Kittner A; Foulkes D; Anderson KW; Evans T; Nicolae L; Staton A; Hardnett C; Townsend MB; Carson WC; Satheshkumar PS; Hutson CL; Gigante CM; Quilter LAS; Gorman S; Borah B; Black SR; Pacilli M; Kern D; Kerins J; McCollum AM; Rao AK; Tabidze I
    Clin Infect Dis; 2024 Jul; 79(1):122-129. PubMed ID: 38567460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mpox Vaccine Interest Survey Prioritization and Data Flow: Maricopa County, Arizona, July-August 2022.
    Howard BJ; Collins JE; Staab RN; Singh S; Lara E; Kretschmer M; Rehder L; Dellos A; White JR; Dale AP
    Am J Public Health; 2023 May; 113(5):504-508. PubMed ID: 36893362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimating the relative importance of epidemiological and behavioural parameters for epidemic mpox transmission: a modelling study.
    Chaturvedi M; Rodiah I; Kretzschmar M; Scholz S; Lange B; Karch A; Jaeger VK
    BMC Med; 2024 Jul; 22(1):297. PubMed ID: 39020322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.